ASST COMMISSIONER OF INCOME TAX , PANVEL vs. EPYGEN BIOTECH PRIVATE LIMITED, NAVI MUMBAI
In the result, appeal of the Revenue is allowed
ITA 2719/PUN/2024[2018-19]Status: DisposedITAT Pune10 Mar 2026AY 2018-19
Bench: Dr. Manish Borad & Shri Vinay Bhamore
For Appellant: Shri Satya Prakash Singh, CAFor Respondent: Shri Nasavarak Jore,atj, Addl.CIT
Section 143(2)Section 143(3)Section 250Section 35(1)(iv)
observing as follows:-
“In ground No.3, regarding the disallowance of capital expenditure related to scientific research amounting to Rs.3,72,88,916 under Section 35(1)(iv) of the Act, the appellant highlighted that the company had commenced its business activities, including the identification of land, construction of the factory ... incurring expenses related to research and development, salaries, and financial costs. The appellant asserted that these expenses, claimed under Section 35(1)(iv) for scientific research, were legitimate and supported by documentary evidence such as invoices, bank statements, and the DSIR registration certificate. The appellant also referenced the decision